MedinCell S.A.
MEDCL.PA · PAR
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 178.8% | -7.9% | 143.1% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | -43.9% | -203.2% | -265.6% | -524.4% |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -72.2% | -273.3% | -321.9% | -606.5% |
| EPS Diluted | -0.63 | -0.88 | -1.27 | -1 |
| % Growth | 28.4% | 30.7% | -27% | – |
| Operating Cash Flow | €0 | -€0 | -€0 | -€0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | €0 | -€0 | -€0 | -€0 |